SCHEMBL2115182

SCHEMBL2115182

[O]C1CCN(C2CCCCC(F)CC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.35
OPRL1 P41146 4/20 0.35
OPRM1 P35372 3/20 0.35
ABCB1 P08183 1/20 0.35
OPRK1 P41145 1/20 0.34
HRH3 Q9Y5N1 3/20 0.34
POLB P06746 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
PHGDH O43175 1/20 0.32
MGLL Q99685 1/20 0.32
ACKR3 P25106 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5266154 0.96 HRH3 (0.36) SLC18A3OPRL1OPRM1ABCB1OPRK1
SCHEMBL2117622 0.91 HRH3 (0.38) SLC18A3OPRL1OPRM1OPRK1HRH3
SCHEMBL2115687 0.91 HRH3 (0.35) HRH3L3MBTL3L3MBTL1
SCHEMBL1828751 0.84 SLC18A3 (0.43) SLC18A3OPRL1OPRM1ABCB1HRH3
SCHEMBL2115192 0.83 OPRM1 (0.32) SLC18A3OPRL1OPRM1OPRK1POLB
SCHEMBL17665810 0.82 SLC18A3 (0.47) SLC18A3OPRL1OPRM1ABCB1HRH3
SCHEMBL2115183 0.82 PHGDH (0.35) SLC18A3OPRM1ABCB1OPRK1HRH3
SCHEMBL2114313 0.82 SLC18A3 (0.34) SLC18A3OPRL1OPRM1ABCB1OPRK1
SCHEMBL16387906 0.80 HRH3 (0.41) SLC18A3ABCB1HRH3L3MBTL3L3MBTL1
SCHEMBL1814912 0.79 SLC18A3 (0.39) SLC18A3OPRL1OPRM1POLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158652-B2 1-Difluoromethyl-5-{4-[3-(1-piperidinyl)propoxy]phenyl}-2(1H)-pyridone; compounds act as histamine-H3 receptor antagonistic substances or inverse-agonistic substances; useful as preventives or remedies for various circular system diseases, nervous system diseases, metabolic system diseases MSD K.K. (JP) 2012-04-17 US disclosed
US-20080269287-A1 Substituted Pyridone Derivative MSD K.K. (JP) 2008-10-30 US disclosed
EP-1820797-A1 SUBSTITUTED PYRIDONE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269287-A1 Substituted Pyridone Derivative HRH3, HRH4, HRH1 SLC18A3 2608/4885OPRL1 188/4885OPRM1 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.